An audit of discharge medication for secondary prophylaxis post-myocardial infarction

Journal of Clinical Pharmacy and Therapeutics

Volumn 21, Issue 6, 1996, Pages 413-416

  Richardson, J ^a,b   Truman, C ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b Crawley Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; RAMIPRIL; TRANDOLAPRIL; WARFARIN;

ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MORTALITY; PRECIPITATION; STANDARD;

EID: 0030433237     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2710.1996.tb00040.x     Document Type: Article

References (18)

1. Health Gain Investment Programme. (1993) For Coronary Heart Disease and Stroke. Technical Review Document, Trent Health, Trent RHA, Sheffield.
2. Second International Study Group of Infarction Survival Collaborative Group. (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither, among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet, 2, 349-360.
3. Antiplatelet Trialists' Collaboration. (1994) Aspirin benefits with vascular disease and those undergoing revascularisation. British Medical Journal, 308, 71-72, 81-106.
4. Yusef S, Peto R, Lewis J, Collins, Sleight P. (1985) Beta blockade during and after myocardial infarction; and overview of the randomised trials. Progress in Cardiovascular Disease, 27, 335-371.
5. Grahame-Clarke BA, Walker JM. (1996) Advancements in the treatment of myocardial infarction. Pharmaceutical Journal Hospital Pharmacy Supplement, 3, 11-15.
6. Pfeffer MA, Braunwald E, Moye LA, et al. (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement (SAVE) Trial. New England Journal of Medicine, 327, 669-677.
7. Fourth International Study of Infarct Survival Collaborative Group (ISIS-4). (1994) A randomised factorial trial assessing early oral captopril, oral mononitrate and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet, 345, 669-685.
8. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. (1993) Effects of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet, 342, 821-828.
9. Kobler L, et al. (1995) Clinical trial of the ACE inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. New England Journal of Medicine, 333, 1670-1676.
10. Ambrosioni E, Borghi C, Magnani B. (1993) The effect of the ACE inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. New England Journal of Medicine, 332, 80-85.
11. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-3). (1994) Effects of lisinopril and transdermal glyceryl trinitrate singly and together on six-week mortality and ventricular function after acute myocardial infarction. Lancet, 343, 669-685.
12. The Health of the Nation. (1992) A Strategy for Health in England, HMSO, London.
13. Eccles M, Bradshaw C. (1991) Use of secondary prophylaxis against myocardial infarction in the north of England. British Medical Journal, 302, 91-92.
14. Whitford DL, Southern AJ. (1994) Audit of secondary prophylaxis after myocardial infarction. British Medical Journal, 309, 1268-1269.
15. Goodman SG, Langer A, Durica SS, et al. (1994) Safety and anticoagulant effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. American Journal of Cardiology, 74(7), 657-661.
16. Stockley IH. (1994) Drug Interactions. 3rd edn, p. 225, Blackwell Scientific Publications, London.
17. Prichard PJ, Kitchingman GK, Walt RP, et al. (1989) Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin. British Medical Journal, 298, 493-496.
18. NHS Executive. (1994) Purchasing and Prescribing EL (94)72. DoH, Leeds.